Primex News International

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Eternal Bright Marks 10 Years With A Fresh Identity And The Same Trusted Formulas

    July 12, 2025

    From Jobs to Juggernauts: PM Modi’s Rozgar Mela Is a Masterclass in Economic Optics

    July 12, 2025

    How to Become an Authorized Person with SMC: Know the Eligibility and Key Benefits

    July 12, 2025
    Facebook Twitter Instagram
    Primex News International
    • Home
    Facebook Twitter Instagram
    Primex News International
    Home»PR»Thyrocare Q4FY25 Revenue Up 21 Percent YoY to Rs 187.2 Cr; PAT Rises 24 Percent to Rs 21.3 Cr
    PR

    Thyrocare Q4FY25 Revenue Up 21 Percent YoY to Rs 187.2 Cr; PAT Rises 24 Percent to Rs 21.3 Cr

    By April 26, 2025No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email

    Navi Mumbai (Maharashtra) [India], April 24: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, announces their results for the quarter ended March 31, 2025. For Q4FY25, the company reported revenue from operations of INR 187.2 crore, reflecting a 21% year-over-year (YoY) growth. Normalized EBITDA for the quarter stood at INR 65.3 crore, marking a robust 78% YoY increase. Profit after tax (PAT), excluding exceptional items, reached INR 32.5 crore, which represents an impressive 88% YoY growth.Thyrocare Technologies Limited

    Key highlights for Q4FY25:

    • Consolidated revenue increased by 21% year-over-year (YoY) with Pathology and Radiology segments growing by 23% YoY and 7% YoY respectively
    • Total volume in FY25 grew to 167.9 million, largest by far on volume
    • Revenue from franchise surged by 22% YoY, and partnership revenue saw 24% YoY growth
    • Consolidated gross margin stood at 74%, and normalized EBITDA margin was 35%
    • Standalone normalized EBITDA grew by 72% YoY, while PAT* increased by 72% YoY
    • Consolidated normalized EBITDA grew by 78% YoY, while PAT* increased by 88% YoY
    • Recommended a final dividend of INR 21 per equity share subject to the approval of shareholders at the ensuing shareholders meeting
    • Consolidated cash reserves as of March 2025 is INR 191.8 Cr
    • Opened new labs in Bhagalpur and Kashmir

    Consolidated income statement for Q4FY25 and FY25:

    Quarter Annual
    INR Crore Q4FY25 Q4FY24 YoY FY25 FY24 YoY
    Revenue from operations 187.2 154.2 21% 687.3 571.9 20%
    Gross margin 137.7 107.6 28% 496.2 405.2 22%
    Normalized EBITDA (before ESOP) 65.3 36.7 78% 209.9 153.1 37%
    Reported EBITDA 57.4 33.8 70% 189.2 137.8 37%
    Profit after tax incl. exceptional item 21.3 17.2 24% 90.0 69.8 29%
    Profit after tax excl. exceptional item 32.5 17.2 88% 101.2 69.8 45%
    Key metrics
    Gross margin% 74% 70% 72% 71%
    Normalized EBITDA% 35% 24% 31% 27%
    Reported EBITDA% 31% 22% 28% 24%
    PAT incl. exceptional item% 11% 11% 13% 12%
    PAT excl. exceptional item% 17% 11% 14% 12%


    * PAT excluding exceptional item of INR 11.2 Cr pertaining to reversal of deferred tax asset created in previous years against the impairment of investment in NHL.

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    PR
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    V6 Sports Launches World-Class Certified DRS System — Built in India, Designed for Global Cricket

    July 8, 2025

    Cricmax Connect: Powering the Organic Growth of Cricket in America

    July 2, 2025

    Tennis Legend Pat Cash Partners with ASE to Launch ‘The Invitational’ with ‘Cash for Charity’ – A Celebration of Tennis and Popular Culture

    July 2, 2025

    Doctor’s Day 2025: Leading Health Experts Offer Practical Tips for Lifelong Wellness

    July 1, 2025

    Doctor’s Day 2025: Leading Health Expert Advice for a Healthier, Happier You

    July 1, 2025

    Happy Square Outsourcing Services Limited IPO Opens On 03rd July 2025

    July 1, 2025

    Comments are closed.

    Top Reviews
    Editors Picks

    Eternal Bright Marks 10 Years With A Fresh Identity And The Same Trusted Formulas

    July 12, 2025

    From Jobs to Juggernauts: PM Modi’s Rozgar Mela Is a Masterclass in Economic Optics

    July 12, 2025

    How to Become an Authorized Person with SMC: Know the Eligibility and Key Benefits

    July 12, 2025

    Packman Engineering: Delivering End-to-End Packaging Solutions with Indian Expertise and Global Vision

    July 12, 2025
    About Us
    About Us
    Our Picks

    Eternal Bright Marks 10 Years With A Fresh Identity And The Same Trusted Formulas

    July 12, 2025

    From Jobs to Juggernauts: PM Modi’s Rozgar Mela Is a Masterclass in Economic Optics

    July 12, 2025

    How to Become an Authorized Person with SMC: Know the Eligibility and Key Benefits

    July 12, 2025
    Top Reviews
    © 2025 Primex News International. Designed by Primex Media Services.
    • Home

    Type above and press Enter to search. Press Esc to cancel.